Étude québécoise sur le cancer du pancréas 
Québec Pancreas Cancer Study
How can genetic testing help?

Traditionally, genetic testing has been offered to patients who have a family history of cancer that is suggestive of a hereditary cancer syndrome, such as hereditary breast and ovarian cancer, certain types of hereditary colorectal cancer, or hereditary melanoma. These syndromes are associated with an increased risk for various cancer types, including pancreas cancer. If an individual is found to carry a genetic change in a gene that causes one of these syndromes, we can then offer genetic testing to other family members. This can help distinguish which family members are at increased risk for cancer, and which family members are not. Screening recommendations for certain cancer types are then available for the family members who do have a higher risk to try to reduce their risk for cancer, and to detect cancer at earlier stages.
Now, as we move from the era of one therapy fits all cancers to a new and exciting era of personalized medicine, we are learning that understanding the genetics of pancreas cancer is helping us to provide more tailored therapies for patients and we are starting to see better results. A better understanding of the genetics of pancreas cancer in Québec will help us advance treatments for Quebecers with this disease.

Are there screening programs for pancreas cancer?
One of the biggest problems with pancreas cancer is that too many cases are detected too late. The prognosis of this disease would likely improve significantly if there was a way to detect it earlier. Unfortunately, there are no screening strategies for pancreas cancer that have been proven to be effective at earlier detection. Internationally, there are several research studies looking at various screening techniques.